Total Clarity Wealth Management’s Sutro Biopharma STRO Stock Holding History

Total Clarity Wealth Management’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20	Closed	-$1K	–	889
2022 Q2	$1K	Buy	+20	New	+$1.12K	﹤0.01%	994
2022 Q1	–	Sell	-20	Closed	-$3K	–	832
2021 Q4	$3K	Hold	20	–	–	﹤0.01%	890
2021 Q3	$4K	Buy	+20	New	+$3.8K	﹤0.01%	864
2021 Q2	–	Sell	-20	Closed	-$5K	–	677
2021 Q1	$5K	Buy	+20	New	+$4.75K	﹤0.01%	702

Other funds holding STRO

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Total Clarity Wealth Management's STRO Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Sutro Biopharma (STRO) in Q3 2022, closing a stake of 20 shares — an estimated $1K sold.

Total Clarity Wealth Management first reported a position in STRO in Q1 2021 and held it in 4 quarters. The position peaked at $5K in Q1 2021. 113 funds tracked by Wall St. Rank hold STRO as of Q3 2022.

Total Clarity Wealth Management reported no remaining Sutro Biopharma position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 20 Sutro Biopharma shares in Q3 2022, an estimated $1K.
Total Clarity Wealth Management first reported a position in Sutro Biopharma in Q1 2021 and held it in 4 quarters.
Total Clarity Wealth Management's Sutro Biopharma position peaked at $5K in Q1 2021.
113 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.